微RNA-204可以预测慢性病患者的功能
Guo Xiaoyun1, Li Hongjun2, Meng Cuijing3
1Department of Nephrology, Second Hospital of Tianjin Medical University, Tianjin, China.
Medicine
|April 4, 2025
概括
慢性病患者的血清microRNA-204 (miR-204) 水平较低,这表明它有可能作为功能和炎症的生物标志物.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 生物标志物 生物标志物
背景情况:
- 慢性病 (CKD) 是一种主要的健康问题,其特点是功能受损.
- 微RNAs (miRNAs) 显示出作为CKD和相关纤维状况的预测和治疗剂的希望.
- 在CKD中研究微RNA-204 (miR-204) 提供了对疾病机制和潜在的临床应用的见解.
研究的目的:
- 在CKD患者中分析miR-204的表达.
- 确定miR-204表达在CKD中的临床意义.
- 在CKD患者中探索miR-204,炎症和纤维化之间的关联.
主要方法:
- 招募了126名CKD患者和126名健康对照.
- 使用逆转录定量聚合酶连锁反应 (RT-qPCR) 来量化血清miR-204水平.
- 炎症性细胞因子和纤维化标志物被评估在血清和淋巴细胞中.
主要成果:
- 与对照组相比,CKD患者表现出炎症性细胞因子 (IL-1β,IL-6,TNF-α,IL-10,IL-17) 的增加.
- 在CKD患者中,血清和质miR-204水平显著降低.
- 较低的miR-204水平与较差的功能,炎症增加和较大的纤维化相关.
结论:
- 在CKD患者中,血清miR-204的下调.
- miR-204 作为一个潜在的生物标志物,用于评估慢性脏病中的功能.
- 在CKD中,miR-204水平与炎症和纤维化严重程度有关.
更多相关视频
05:39Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
1.8K
06:48Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
Published on: April 29, 2022
2.2K
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
37
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
37
01:11Renal Failure: Dose Adjustments
46
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
46